| Literature DB >> 26925290 |
K Lalrinzuali1, M Vabeiryureilai1, Ganesh Chandra Jagetia1.
Abstract
Inflammation is all a pervasive phenomenon, which is elicited by the body in response to obnoxious stimuli as a protective measure. However, sustained inflammation leads to several diseases including cancer. Therefore it is necessary to neutralize inflammation. Sonapatha (Oroxylum indicum), a medicinal plant, is traditionally used as a medicine in Ayurveda and other folk systems of medicine. It is commonly used to treat inflammatory diseases including rheumatoid arthritis and asthma. Despite this fact its anti-inflammatory and analgesic effects are not evaluated scientifically. Therefore, the anti-inflammatory and analgesic activities of Sonapatha (Oroxylum indicum) were studied in Swiss albino mice by different methods. The hot plate, acetic acid, and tail immersion tests were used to evaluate the analgesic activity whereas xylene-induced ear edema and formalin induced paw edema tests were used to study the anti-inflammatory activity of Sonapatha. The administration of mice with 250 and 300 mg/kg b.wt. of O. indicum reduced pain and inflammation indicating that Sonapatha possesses analgesic and anti-inflammatory activities. The maximum analgesic and anti-inflammatory activities were observed in mice receiving 300 mg/kg b.wt. of O. indicum ethanol extract. Our study indicates that O. indicum possesses both anti-inflammatory and analgesic activities and it may be useful as an anti-inflammatory agent in the inflammation related disorders.Entities:
Year: 2016 PMID: 26925290 PMCID: PMC4746378 DOI: 10.1155/2016/8247014
Source DB: PubMed Journal: Int J Inflam ISSN: 2042-0099
Effect of Oroxylum indicum on the analgesic activity in mice by hot plate test.
| Treatment | Dose (mg/kg b.wt.) | Mean ± SEM | Increase in latency period (%) | |
|---|---|---|---|---|
| Pretreatment reaction latency(s) | Posttreatment reaction latency(s) | |||
| Control | 0 | 7.60 ± 0.58 | 7.60 ± 0.45 | 0 |
| OIE | 300 | 8.00 ± 0.32 | 13.20 ± 1.07 | 62.5 |
| OIE | 250 | 7.60 ± 0.89 | 11.60 ± 1.04 | 52.63 |
| Diclofenac | 20 | 7.60 ± 0.55 | 13.40 ± 0.84 | 76.31 |
N = 10.
P < 0.05 when compared to SPS treated control.
Effect of ethanol extract of Oroxylum indicum on xylene-induced ear edema in mice.
| Treatment | Dose (mg/kg b.wt.) | Mean increase in ear weight (mg) ± SEM | % Inhibition |
|---|---|---|---|
| Control | 0 | 13.98 ± 0.60 | — |
| OIE | 300 | 4.00 ± 0.24 | 71.39 |
| 250 | 4.46 ± 0.89 | 68.10 | |
| Diclofenac | 20 | 6.61 ± 0.49 | 52.72 |
N = 10.
P < 0.05 when compared to SPS treated control.
Figure 1Effect of ethanol extract of Oroxylum indicum on the formalin induced inflammation in mice paw.
Alteration in the analgesic activity by acetic acid induced writhing in mice treated with different doses of Oroxylum indicum.
| Treatment | Dose (mg/kg b.wt.) | Mean ± SEM | Percentage inhibition of writhing (%) |
|---|---|---|---|
| Number of writhes | |||
| Control | 0 | 66.2 ± 1.16 | 0 |
| OIE | 300 | 20.8 ± 0.74 | 68.58 |
| 250 | 22.5 ± 1.12 | 66.01 | |
| Diclofenac | 20 | 10.8 ± 0.74 | 83.68 |
N = 10.
P < 0.05 when compared to SPS treated control.
Alteration in the response time in mice treated with Oroxylum indicum before subjecting them to tail immersion test.
| Treatment | Dose (mg/kg b.wt.) | Response time in seconds ± SEM | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Assessment time (h) | |||||||||
| 0 | 0.5 | 1 | 2 | 3 | 4 | 5 | 6 | ||
| Control | 0 | 4.30 ± 0.05 | 4.2 ± 0.20 | 4.03 ± 0.12 | 4.6 ± 0.35 | 4.81 ± 0.51 | 4.62 ± 0.42 | 4.31 ± 0.37 | 4.30 ± 0.40 |
|
| |||||||||
| OIE | 300 | 5.67 ± 0.20 | 6.33 ± 0.15 | 6.78 ± 0.51 | 8.80 ± 0.06 | 7.56 ± 0.05 | 6.98 ± 0.15 | 6.80 ± 0.20 | 6.61 ± 0.27 |
| (11.64) | (19.57) | (55.20) | (33.33) | (23.10) | (19.92) | (16.57) | |||
| 250 | 4.69 ± 0.50 | 4.72 ± 0.08 | 4.97 ± 0.30 | 4.78 ± 0.46 | 7.14 ± 0.54 | 5.65 ± 0.65 | 4.90 ± 0.15 | 4.80 ± 0.10 | |
| (1.91) | (5.97) | (19.18) | (52.23) | (20.46) | (4.47) | (2.35) | |||
|
| |||||||||
| Diclofenac | 20 | 4.29 ± 0.08 | 4.43 ± 0.20 | 5.03 ± 0.11 | 6.76 ± 0.5 | 7.31 ± 0.57 | 6.87 ± 0.48 | 6.39 ± 0.47 | 4.50 ± 0.70 |
| (3.26) | (17.29) | (57.57) | (70.39) | (60.13) | (48.95) | (4.89) | |||
Inhibition (%) is shown in brackets.
N = 10.
P < 0.05 when compared to SPS treated control.